Use of frontline maintenance treatment following cytoreductive surgery in advanced high-grade serous ovarian cancer: a memorial Sloan Kettering team ovary study

被引：0
|
作者：
Finch, Lindsey [1 ]
Finlan, Michael [1 ]
Broach, Vance [1 ]
Chi, Dennis [1 ]
Roche, Kara Long [1 ]
Gardner, Ginger [1 ]
Al-Niaimi, Ahmed [1 ]
O'cearbhaill, Roisin [2 ]
Grisham, Rachel [2 ]
Abu-Rustum, Nadeem [1 ]
Sonoda, Yukio [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Surg, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Med, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV254/#957
引用
收藏
页码：A215 / A215
页数：1
相关论文
共 50 条
  • [31] Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study
    Li, Xiaoxue
    Ding, Yiling
    Liu, Yang
    Yang, Mengyuan
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [32] Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment
    Vetter, Marcus
    Stadlmann, Sylvia
    Bischof, Evelyne
    Margarint, Elena Laura Georgescu
    Schotzau, Andreas
    Singer, Gad
    Heinzelmann-Schwarz, Viola
    Montavon, Celine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [33] BRCA mutational status to personalize upfront management in high-grade serous advanced ovarian cancer: A multicenter study
    Petrillo, M.
    Marchetti, C.
    De Leo, R.
    Musella, A.
    Capoluongo, E.
    Paris, I.
    Benedetti-Panici, P.
    Scambia, G.
    Fagotti, A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 84 - 85
  • [34] Clinical characteristics and treatment modalities in women with newly diagnosed advanced high-grade serous epithelial ovarian cancer in Taiwan
    Hsu, Heng-Cheng
    Chou, Hung-Hsueh
    Cheng, Wen-Fang
    Chang, Chih-Long
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (11) : 1167 - 1174
  • [35] Investigating the impact of interval from primary debulking surgery to initiation of adjuvant chemotherapy in advanced high-grade serous ovarian cancer
    Lee, Y.
    Lu, L.
    Xu, W.
    Brown, T.
    May, T.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 185 - 185
  • [36] Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study
    Hu, Dongzhi
    Ma, Dongdong
    Zhang, Zi-jian
    Zhang, Yongjing
    Huang, Kangni
    Li, Xiaoxue
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [37] The use of novel PP2A activators in combination with PARP inhibitor for the treatment of high-grade serous ovarian cancer
    Armstrong, A. J.
    Joseph, P.
    Nagaraj, A. B.
    Nagel, C. I.
    Nakayama, J.
    Waggoner, S. E.
    Zanotti, K. M.
    DiFeo, A.
    Narla, G.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 73 - 73
  • [38] Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis
    Kim, Soyoun Rachel
    Parbhakar, Ashna
    Li, Xuan
    Bernardini, Marcus Q.
    Hogen, Liat
    May, Taymaa
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (06) : 879 - 885
  • [39] Residual Microscopic Peritoneal Metastases after Macroscopic Complete Cytoreductive Surgery for Advanced High-Grade Serous Ovarian Carcinoma: A Target for Folate Receptor Targeted Photodynamic Therapy?
    Moinard, Morgane
    Augustin, Jeremy
    Carrier, Marine
    Da Maia, Elisabeth
    Penel, Alix
    Belghiti, Jeremie
    Nikpayam, Maryam
    Gonthier, Clementine
    Canlorbe, Geoffroy
    Acherar, Samir
    Delhem, Nadira
    Frochot, Celine
    Uzan, Catherine
    Azais, Henri
    PHARMACEUTICALS, 2022, 15 (08)
  • [40] A Computed Tomography-Based Radiomic Prognostic Marker of Advanced High-Grade Serous Ovarian Cancer Recurrence: A Multicenter Study
    Wei, Wei
    Liu, Zhenyu
    Rong, Yu
    Zhou, Bin
    Bei, Yan
    Wei, Wei
    Wang, Shuo
    Wang, Meiyun
    Guo, Yingkun
    Tian, Jie
    FRONTIERS IN ONCOLOGY, 2019, 9
12345